Publications in collaboration with researchers from Instituto de Investigación Sanitaria del Hospital Universitario La Paz (18)

2025

  1. Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders

    Journal of Clinical Immunology, Vol. 45, Núm. 1

2024

  1. An Exploratory Approach of Clinically Useful Biomarkers of Cvid by Logistic Regression

    Journal of Clinical Immunology, Vol. 44, Núm. 6

  2. Exploring gastric cancer genetics: A turning point in common variable immunodeficiency

    Journal of Allergy and Clinical Immunology: Global, Vol. 3, Núm. 2

  3. Inherited Human BCL10 Deficiencies

    Journal of Clinical Immunology, Vol. 44, Núm. 1

  4. Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study

    Experimental Dermatology, Vol. 33, Núm. 8

2023

  1. Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa

    British Journal of Dermatology, Vol. 189, Núm. 6, pp. 774-776

  2. Inherited human ezrin deficiency impairs adaptive immunity

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 4, pp. 997-1009.e11

  3. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

2022

  1. Case Report: Novel STIM1 Gain-of-Function Mutation in a Patient With TAM/STRMK and Immunological Involvement

    Frontiers in Immunology, Vol. 13

  2. Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression

    Biomedicines, Vol. 10, Núm. 8

  3. Genomic crossroads between non-Hodgkin’s lymphoma and common variable immunodeficiency

    Frontiers in Immunology, Vol. 13

2021

  1. Clinical and Immunological Features of Human BCL10 Deficiency

    Frontiers in Immunology, Vol. 12

  2. Serological tests in the detection of SARS-CoV-2 antibodies

    Diagnostics, Vol. 11, Núm. 4

2020

  1. Evaluation of Polysaccharide Typhim Vi Antibody Response as a predictor of Humoral Immunodeficiency in Haematological Malignancies

    Clinical Immunology, Vol. 210

  2. Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?

    Frontiers in Immunology, Vol. 11

  3. Trained immunity based-vaccines as a prophylactic strategy in common variable immunodeficiency. A proof of concept study

    Biomedicines, Vol. 8, Núm. 7

  4. Typhim vi immunization assists to discriminate primary antibody responses in hematological malignancies

    MethodsX, Vol. 7

  5. Variable immunodeficiency study: Evaluation of two European cohorts within a variety of clinical phenotypes

    Immunology Letters, Vol. 223, pp. 78-88